BeOne Medicines Ltd.
- Stock
- Ticker ONC
- ISIN US07725L1026
- Nasdaq
- US listing in dollars (ADR)
Performance, volatility and drawdowns of BeOne Medicines Ltd. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $124,069. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −70.0% in 05/2022, measured from the peak in 09/2021. It took 62 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 1,128 | 1,117 | 1,315 | 1,412 | 1,498 | 1,513 | 1,705 | 1,890 |
| Gross profit | 967 | 952 | 1,151 | 1,216 | 1,356 | 1,346 | 1,531 | 1,673 |
| Operating income | -79 | 11 | 88 | 163 | 185 | 250 | 325 | 419 |
| EBITDA | -29 | 44 | 118 | 199 | 221 | 291 | 364 | 456 |
| Net income | -152 | 1.3 | 94 | 125 | 67 | 227 | 237 | 385 |
| Earnings per share | -1.42 | 0.01 | 0.84 | 1.09 | 0.57 | 1.96 | 2.05 | 3.28 |
| Balance sheet | ||||||||
| Total assets | 5,921 | 5,842 | 6,298 | 7,633 | 8,189 | 8,554 | 9,176 | 9,876 |
| Liabilities | 2,589 | 2,342 | 2,528 | 3,503 | 3,827 | 3,793 | 4,002 | 4,056 |
| Equity | 3,332 | 3,500 | 3,770 | 4,129 | 4,361 | 4,760 | 5,174 | 5,820 |
| Cash | 2,627 | 2,516 | 2,756 | 4,037 | 4,548 | 4,792 | 5,098 | 5,781 |
| Long-term debt | 166 | 160 | 146 | – | 962 | 963 | 882 | 825 |
| Cash flow | ||||||||
| Operating cash flow | 75 | 44 | 264 | 403 | 417 | 201 | 463 | 509 |
| Capital expenditure | -92 | -56 | -44 | -48 | -38 | -41 | -27 | -35 |
| Free cash flow | -17 | -12 | 220 | 354 | 380 | 161 | 435 | 474 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +221.9%, weakest 2022 at −18.8%. 7 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | $3.28 |
| 5 Aug 2026 | $2.05 |
| 6 May 2026 | $1.96 |
| 26 Feb 2026 | $0.57 |
| 6 Nov 2025 | $1.09 |
| 6 Aug 2025 | $0.84 |
| 7 May 2025 | $0.01 |
| 27 Feb 2025 | −$1.42 |
| 12 Nov 2024 | −$1.15 |
| 7 Aug 2024 | −$1.15 |
| 8 May 2024 | −$2.41 |
| 26 Feb 2024 | −$3.53 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €40bn
- Market cap in trading currency
- $44.7bn
- Enterprise value
- $39.7bn
- P/E
- 49.7
- P/S
- 6.76
- P/B
- 7.67
- EV/Sales
- 6.02
- EV/EBITDA
- 29.8
- Earnings yield
- 2.0%
- FCF yield
- 3.2%
Results (last four quarters)
- Revenue
- $6.61bn
- Gross profit
- $5.91bn
- EBITDA
- $1.33bn
- Net income
- $916m
- Earnings per share
- $7.86
- Revenue per share
- $57.84
- Revenue growth
- +33.8%
- Earnings growth
- +208.2%
Profitability
- Gross margin
- 89.4%
- Operating margin
- 17.8%
- Net margin
- 13.9%
- Return on equity
- 18.4%
- Return on assets
- 9.3%
Balance sheet and cash flow
- Cash
- $5.78bn
- Cash per share
- $50.61
- Financial debt
- $866m
- Debt/equity %
- 15
- Current ratio
- 3.55
- Book value per share
- $50.96
- Operating cash flow
- $1.59bn
- Free cash flow
- $1.45bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 114m
- Volume
- 356,774
- Avg. volume 3 months
- 404,016
- Relative volume
- 0.9
Price and technicals
- Price
- $390.94
- 1 day
- −2.2%
- 52-week high
- $424.00
- 52-week low
- $260.27
- Distance to 52-week high
- −7.8%
- Distance to 52-week low
- +50.2%
- Distance to 50-day line
- +4.4%
- Distance to 200-day line
- +18.7%
- RSI (14)
- 50
- Volatility 1M
- 37.8%
Performance
- 1 week
- −6.1%
- 1 month
- +2.3%
- 3 months
- +5.1%
- 6 months
- +26.0%
- YTD
- +28.7%
- 1 year
- +10.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ONC performed since 11/2016?
$10,000 grew to $124,069 by 20 Nov 2026, which is +28.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ONC?
Volatility was 52.2% per year, measured on monthly returns. The largest decline from a peak was −70.0%, with the low in 05/2022.
How does ONC compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ONC returned +28.7% at 52.2%. The correlation of monthly returns was 0.25; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's depositary receipt (ADR) traded in the US. On individual days its path differs slightly from the price on the home exchange.